These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37839636)

  • 81. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
    Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
    Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
    Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
    Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Knockdown of ubiquitin-specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c-Myc expression.
    Huang J; Gu ZL; Chen W; Xu YY; Chen M
    Kaohsiung J Med Sci; 2020 Aug; 36(8):615-621. PubMed ID: 32255563
    [TBL] [Abstract][Full Text] [Related]  

  • 85. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
    Wang L; Zhang X; Jia LT; Hu SJ; Zhao J; Yang JD; Wen WH; Wang Z; Wang T; Zhao J; Wang RA; Meng YL; Nie YZ; Dou KF; Chen SY; Yao LB; Fan DM; Zhang R; Yang AG
    Hepatology; 2014 May; 59(5):1850-63. PubMed ID: 24002871
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma.
    Li M; Li C; Liu WX; Liu C; Cui J; Li Q; Ni H; Yang Y; Wu C; Chen C; Zhen X; Zeng T; Zhao M; Chen L; Wu J; Zeng R; Chen L
    J Mol Cell Biol; 2017 Dec; 9(6):489-503. PubMed ID: 28655161
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells.
    Gao J; Dong Y; Zhang B; Xiong Y; Xu W; Cheng Y; Dai M; Yu Z; Xu H; Zheng G
    Int J Oncol; 2012 Nov; 41(5):1773-81. PubMed ID: 22922832
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability.
    Zhou X; Wen Y; Tian Y; He M; Ke X; Huang Z; He Y; Liu L; Scharf A; Lu M; Zhang G; Deng Y; Yan Y; Mayer MP; Chen X; Zou F
    Hepatology; 2019 Apr; 69(4):1564-1581. PubMed ID: 30015413
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells.
    Huan HB; Wen XD; Chen XJ; Wu L; Wu LL; Zhang L; Yang DP; Zhang X; Bie P; Qian C; Xia F
    Brain Behav Immun; 2017 Jan; 59():118-134. PubMed ID: 27585737
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.
    Du L; Ji Y; Xin B; Zhang J; Lu LC; Glass CK; Feng GS
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1351-1369. PubMed ID: 36828281
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.
    Zhang F; Hu K; Liu W; Quan B; Li M; Lu S; Chen R; Ren Z; Yin X
    Cell Mol Gastroenterol Hepatol; 2023; 15(3):573-591. PubMed ID: 36513250
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W; Chen X; Chi W; Xue M
    Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
    [TBL] [Abstract][Full Text] [Related]  

  • 96. miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.
    Liu X; Li J; Yu Z; Li J; Sun R; Kan Q
    Oncol Res; 2017 Mar; 25(3):427-435. PubMed ID: 27697092
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
    Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
    Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma.
    Chen F; Yang L; Peng X; Mao M; Liu X; Song J; Hu J
    Mol Immunol; 2022 Nov; 151():204-217. PubMed ID: 36179603
    [TBL] [Abstract][Full Text] [Related]  

  • 99. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
    Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
    Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
    [TBL] [Abstract][Full Text] [Related]  

  • 100. XBP1s repression regulates Kupffer cell polarization leading to immune suppressive effects protecting liver allograft in rats.
    Zhang W; Cao D; Wang M; Wu Y; Gong J; Li J; Liu Y
    Int Immunopharmacol; 2021 Feb; 91():107294. PubMed ID: 33395585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.